
Service Catalog
Service Categories | Service Description | Platforms Used | Turnaround Time | Notes |
---|---|---|---|---|
PK/PD studies, Biodistribution, Metabolites |
mAbs, Peptides, Recombinant Proteins, Bi/multispecific Abs, T Cell Engagers, ADCs and Vaccines |
ELISA, MSD, LBA-LC-MS/MS, ELISpot | Method Dev: 2 - 4 Weeks Sample Analysis: 2 Weeks |
Assist in PK/PD design, support PK/PD rodent testing |
RNAi, siRNA, miRNA, ASO, and mRNA/DNA therapies | qPCR/RT-qPCR, ddPCR, Hybridization ELISA, LC-MS, ISH, Northern Blot |
Method Dev: 3 - 4 Weeks Sample Analysis: 2 Weeks |
Expedited service available | |
AAV Vector-Mediated, LNP Delivery, CRISPR and Ex Vivo / In Vivo CAR-T/NK-T, TCR, TIL Therapy and HSCT / IPSCs |
qPCR, RT-qPCR, ddPCR, NGS, Western Blotting, ELISA, Flow Cytometry, ICS, ICC, MSD, Vector Shedding, Pre-Existing Ab Screening |
Method Dev: 3 - 4 Weeks Sample Analysis: 2 Weeks |
Expedited service available | |
Chemical Compounds, Inhibitors and PROTAC & Molecular Glues |
HPLC/UPLC, LC-MS, LC-MS/MS, SPE | Method Dev: 2 - 4 Weeks Sample Analysis: 2 Weeks |
Expedited service available | |
Biomarker Testing | Protein, Cytokines/Chemokines and Biomarker Biofluid Sample |
ELISA, MSD, Western Blotting, Mass Spectroscopy |
Method Dev: 3 - 4 Weeks Sample Analysis: 2 Weeks |
|
DNA/RNA Biomarker, ctDNA and cfDNA | qPCR/RT-qPCR, ddPCR, NGS | Method Dev: 4 - 6 Weeks Sample Analysis: 2 - 3 Weeks |
||
Cell Biomarker Assays, T and B Cell Immunophenotyping, ICS and scRNA-Seq |
Flow Cytometry, ELISpot, NGS | Method Dev: 3 - 4 Weeks Sample Analysis: 2 Weeks |
||
Immunogenicity Detection | ADA, Pre-Existing Antibody and Neutralizing Antibody | MSD, ELISA, Cell-Based Assays | Method Dev: 3 - 4 Weeks Sample Analysis: 2 Weeks |
|
Toxicology Analysis | PK/PD, TK/TD, Toxic Biomarker Analysis, Tissue Distribution and Metabolites |
ELISA, LC-MS/MS, qPCR, NGS, Western Blot |
Method Dev: 3 - 4 Weeks Sample Analysis: 2 Weeks |
Assist in toxicology experimental design |
Cell-Based Assays | ELISpot Assays, Intracellular Cytokine Staining (ICS) by Flow Cytometry, Nab, MTT Assay, Luciferase Reporter Assay, ATP-Based Cytotoxicity Assay, Phosphorylation-Specific Antibody Assays, Cell-Based ELISA, GFP/RFP Fluorescence Assays |
Cell Culture, SpectraMax ID5, ELISA, ELISpot, Li-Cor Odyssey, Western Blotting |
Varies | |
Genomics and Transcriptomics Analysis | Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing Sequencing (RNA-Seq), Single-Cell RNA Sequencing (scRNA-Seq), CRISPR/Cas9 Genome Editing, Single Nucleotide Polymorphism (SNP) Analysis |
Sanger Sequencing, Next-Generation Sequencing |
Varies | |
Proteomics and Metabolomics | Peptide Sequencing, Protein Identification, Protein Quantification-Label-Free (SILAC), Isotopic Labeling (iTRAQ), Phosphoproteomics, Chemoproteomics, Biomarker Discovery, Relative and Absolute Quantification metabolics, Shotgun Lipidomics, Pathway Mapping |
LC-MS, and LC-MS/MS, IMS, HPLC, 2D-PAGE | Varies | |
*Please note that all turnaround times are estimates. Specific timelines will vary based on the exact nature of the project, the level of method development required and additional factors. |